Pitavastatin Magnesium + Erythromycin Interaction
Unknowninteraction on record
Description
Erythromycin Clinical Impact: Erythromycin significantly increases pitavastatin exposure and increases the risk of myopathy and rhabdomyolysis . Intervention: In patients taking erythromycin, do not exceed ZYPITAMAG 1 mg once daily [see Dosage and Administration ( 2.4 )].
Source: FDA drug label - pitavastatin magnesium